missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ATAD5 (aa 1255-1351) Control Fragment Recombinant Protein
Click to view available options
Menge:
100 μl
Packungsgröße:
100 Mikroliter
Beschreibung
Highest antigen sequence indentity to the following orthologs: Mouse (81%), Rat (81%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-140323 (PA5-140323. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Involved in DNA damage response. Involved in a RAD9A-related damage checkpoint, a pathway that is important in determining whether DNA damage is compatible with cell survival or whether it requires cell elimination by apoptosis. Modulates the RAD9A interaction with BCL2 and thereby induces DNA damages-induced apoptosis. [UniProt]
Spezifikation
Spezifikation
| Zugriffsnummer | Q96QE3 |
| Konzentration | ≥5.0 mg/mL |
| Zur Verwendung mit (Anwendung) | Blocking Assay, Control |
| Zusammensetzung | 1 M urea, PBS with no preservative; pH 7.4 |
| Gen-ID (Entrez) | 79915 |
| Name | Human ATAD5 (aa 1255-1351) Control Fragment |
| Menge | 100 μl |
| Kennzeichnung | RUO |
| Gen-Alias | ATAD5; ATPase family AAA domain-containing protein 5; ATPase family, AAA domain containing 5; C130052G03Rik; C17orf41; chromosome fragility associated gene 1; chromosome fragility-associated gene 1 protein; ELG1; enhanced level of genomic instability 1 homolog; FLJ12735; FRAG1; Gm17; RGD1561464 |
| Gebräuchliche Bezeichnung | ATAD5 |
| Mehr anzeigen |
Berichtigung von Produktinhalten
Bitte geben Sie uns Ihr Feedback zu den Produktinhalten, indem Sie das folgende Formular ausfüllen.
Name des Produkts
Haben Sie Verbesserungsvorschläge?Übermitteln Sie eine inhaltliche Korrektur